Vera Bunyatyan

Vera Bunyatyan

Auto-generated profile, based on publicly available information

Vera Bunyatyan

I. M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2021 in ScienceRise: Pharmaceutical Science
Verified
Journal Article
Open access
PDF file
MMMykhailo Myha
Mykhailo Myha
Oleh KoshovyiOleh Koshovyi
Oleh Koshovyi
YKYevhen Karpun
Yevhen Karpun
AKAlla M. Kovaleva
Alla M. Kovaleva
OMOlga Mala
Olga Mala
Sergiy M. KovalenkoSergiy M. Kovalenko
Sergiy M. Kovalenko
The genus Salvia L. has more than 900 species distributed throughout the globe. 21 species are growing in Ukraine. All species of this genus have essential oils. Salvia officinalis and Salvia sclarea have been used in the culture and are widely used in medical practice. The chemical composition of other species of sage and the possibility of their use in pharmaceutical and medical practice are almost not studied. Taking into account the results of chemotaxonomic studies of species of the flora genus of Ukraine, their prevalence and prospects for introduction into the culture, for further studies were selected raw materials of S. grandiflora, S. pratensis and S. verticillata. The aim. The aim of the study was to conduct a chromato-mass spectrometric study of the aboveground organs of S. grandiflora L., S. pratensis L. and S. verticillata L. to establish the prospects for the use of raw materials of these species in medical and pharmaceutical practice. Materials and methods. The objects of the study were leaves of S. officinalis, leaves, stems and flowers of S. grandiflora, S. pratensis and S. verticillata, which were harvested on the basis of the botanical garden of Ivan Franko National University of Lviv. The research of volatile substances in the objects of the research was carried out by the method of GC-MS on the basis of the Department of Natural Sciences for Foreign Students and Toxicological Chemistry of Zaporizhia State Medical University. Results. As a result of the study, 243 substances were found in the objects of the study, of which 149 were identified. 77 substances were found in the leaves of S. officinalis, 80, 26 and 63 substances in the leaves, stems and flowers of S. grandiflora, respectively, in the leaves , stems and flowers of S. pratensis – 28, 30 and 48 substances, respectively, in leaves, stems and flowers of S. verticillata – 39, 22 and 39 substances, respectively. Dominant compounds among substances of terpenoid nature are: cyclofenchene, camphene, 1,8-cineole, α-thujone, β-thujone, camphor borneol, caryophyllene, humulene, viridiflorol, sabinene, pyranone, β-pinene, phytol, kolavenol, β-copaen, loliolide, pseudolimonene and spatulenol. Among the dominant substances, 8 were detected for the first time in these species: cyclofenchene, viridiflorol, sabinene, pyranone, phytol, kolavenol, loliolide and pseudolimonene. Conclusions. The leaves of S. officinalis, leaves, stems and flowers of S. grandiflora, S. pratensis and S. verticillata of the flora of Ukraine were studied by chromato-mass spectrometric method. As a result of the study, 243 substances were identified, of which 149 were identified. Promising raw materials containing terpene compounds for S. grandiflora there are leaves, and for S. pratensis and S. verticillata – flowers, so they are promising agents for introduction into pharmaceutical practice

31 August 2020 in ScienceRise: Pharmaceutical Science
Verified
Journal Article
Closed access
ASAnton Semenets
Anton Semenets
MSMarharyta Suleiman
Marharyta Suleiman
VGVictoriya A. Georgiyants
Victoriya A. Georgiyants
Sergiy M. KovalenkoSergiy M. Kovalenko
Sergiy M. Kovalenko
NKNatalia Kobzar
Natalia Kobzar
LPLina Perekhoda
Lina Perekhoda

19 June 2020 in Research Results in Pharmacology
Verified
Journal Article
Open access
PDF file
Hanna SeverinaHanna Severina
Hanna Severina
OSOlga O. Skupa
Olga O. Skupa
NVNatalya I. Voloshchuk
Natalya I. Voloshchuk
NSNarzullo Saidov
Narzullo Saidov
VBVera A. Bunyatyan
Vera A. Bunyatyan
VGVictoriya A. Georgiyants
Victoriya A. Georgiyants
Introduction: The search for new anticonvulsants for epilepsy treatment with higher efficacy and better tolerability remains important. The aim of the present research was an in silico and in vivo pharmacological study of N-(3,4-di­methoxyphenyl)-2-((2-methyl-6-(pyridin-2-yl)pyrimidin-4-yl)thio)acetamide (Epirimil) as a promising anticonvulsant. Materials and methods: A 1H and 13C NMR spectroscopy, LS/MS, and an elemental analysis were used to deter­mine Epirimil structure. An ADMET analysis, as well as a docking study using anticonvulsant biotargets, e.g.: GAB­AAR, GABAAT, CA II, NMDAR, and AMPAR, was carried out. Anticonvulsant activity was proved, using PTZ- and MES-induced seizures in rats and mice, and neurotoxicity was determined using a rotarod test. Influence of Epirimil on the psycho-emotional state of the laboratory animals was determined by an open field test. Results and discussion: A synthesis method of a promising anticonvulsant Epirimil was modified. The calculated ADMET parameters and a molecular docking into the active sites of anticonvulsant biotargets allowed evaluating the research prospects and predicting possible mechanisms for implementing anticonvulsant activity. A prominent anticonvulsant activity of Epirimil was established using in vivo studies on the model of PTZ-induced seizures in rats and MES-induced seizures in mice. In terms of toxicity, Epirimil belongs to class IV – low toxic substances. The open field test showed that Epirimil had almost no effect on the animals’ behavioral responses: it neither changed their psy­cho-emotional activity, nor increased their anxiety level. ED50, TD50 and protective index of Epirimil according to its anticonvulsant activity were calculated. Conclusion: The obtained experimental results substantiate the prospects of N-(3,4-Dimethoxyphenyl)-2-((2-methyl-6-(pyridin-2-yl)pyrimidin-4-yl)thio)acetamide as a promising active pharmaceutical ingredient having a multifactor mechanism of anticonvulsant activity. Graphical